Search filters

List of works by David Reiner

Biphenylalkoxyamine Derivatives-Histamine H Receptor Ligands with Butyrylcholinesterase Inhibitory Activity

scientific article published on 11 June 2021

Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease

scientific article published in September 2021

Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands

scientific article published on 21 June 2018

Discovery of Potential, Dual-Active Histamine H Receptor Ligands with Combined Antioxidant Properties

scientific article published on 15 April 2021

Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors

scientific article published on 12 May 2020

Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1h-indole like derivatives against the human histamine H4 receptor

scientific article published on 02 October 2020

Histamine H3 receptor antagonists/inverse agonists: Where do they go?

scientific article published on 24 April 2019

Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects

scientific article published on 24 January 2019

In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes

scientific article published on 12 November 2019

Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring

scientific article published on 28 January 2019

Novel naphthyloxy derivatives - Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation.

scientific article published on 11 April 2018

Rasagiline derivatives combined with histamine H3 receptor properties

scientific article published on 09 August 2019

The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice

scientific article published on 03 June 2020

The Search for Histamine H 4 Receptor Ligands with Anticancer Activity among Novel (Thio)urea Derivatives

scientific article published on 29 September 2019

The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice

scientific article published on 30 July 2019